Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Greggory M. Gahn"'
Autor:
Greggory M. Gahn, Arshad M. Khanani, Majid Khan, Aamir A. Aziz, Fawwaz A. Siddiqui, Nikolas JS. London, Lekha K. Mukkamala, Lawrence S. Morse
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 20, Iss , Pp 100892- (2020)
Externí odkaz:
https://doaj.org/article/f4deab7f3a7e4c50b2bfa195fbbf0ffc
Autor:
Greggory M. Gahn, Arshad M. Khanani
Publikováno v:
Vision, Vol 2, Iss 1, p 15 (2018)
Neovascular age-related macular degeneration is a leading cause of vision loss among the aging population. The current standard of care to treat neovascular age-related macular degeneration is inhibiting vascular endothelial growth factor (VEGF) thro
Externí odkaz:
https://doaj.org/article/21318e2015e044f4a2d7f0059f12a7bc
Autor:
Julia A. Haller, Mitchell S. Fineman, Arshad M. Khanani, Victor H. Gonzalez, Greggory M Gahn, Hamzah Khalaf, Joseph Coney, Joseph I. Markoff
Publikováno v:
Journal of VitreoRetinal Diseases. 3:332-340
Purpose: This article compares bilateral visual outcomes in patients receiving a vitrectomy in one eye for a full-thickness macular hole (FTMH) who also received ocriplasmin treatment in the fellow eye for symptomatic vitreomacular adhesion (VMA). Me
Autor:
Greggory M Gahn, Arshad M. Khanani, Sandra M. Brown, Jonathan M Dang, Micaela Koci, Lauren Hill
Publikováno v:
Clinical Ophthalmology. 13:347-351
Objective To assess outcomes in treatment-naive eyes with neovascular age-related macular degeneration (nAMD) and good baseline visual acuity (VA) treated using a treat-and-extend (TE maximum interval of 12 weeks. Medication changed if edema recurred
Autor:
Aamir A Aziz, Arshad M. Khanani, Fawwaz Siddiqui, Lawrence S Morse, Majid Khan, Greggory M. Gahn, Lekha Mukkamala, Nikolas Js London
Publikováno v:
American Journal of Ophthalmology Case Reports
American Journal of Ophthalmology Case Reports, Vol 20, Iss, Pp 100892-(2020)
American Journal of Ophthalmology Case Reports, Vol 20, Iss, Pp 100892-(2020)
Autor:
Arshad M, Khanani, Greggory M, Gahn, Micaela M, Koci, Jonathan M, Dang, Sandra M, Brown, Lauren F, Hill
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Objective To assess outcomes in treatment-naive eyes with neovascular age-related macular degeneration (nAMD) and good baseline visual acuity (VA) treated using a treat-and-extend (T&E) regimen with intravitreal aflibercept, ranibizumab, or bevacizum